Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110121 · ClinicalTrials.gov registry record · NA
Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos
A NA study of Unwanted Tattoos, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT02110121 is a NA study of Unwanted Tattoos that has completed, run by Cynosure. The registered enrollment target is 63 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02110121, a NA study of Unwanted Tattoos, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the Picosure and Revlite Laser Systems for the treatment of unwanted tattoos.
Conditions Studied
Interventions
- DEVICE Picosure Laser System
- DEVICE Revlite Laser System
Study Locations (1)
Massachusetts
- Cynosure Inc. - Westford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02110121
The ClinicalTrials.gov registry entry for NCT02110121 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unwanted Tattoos appearing as the primary indexed condition, and to 2 interventions - of which Picosure Laser System is the first listed.
NCT02110121 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02110121 about?
NCT02110121 is a clinical study titled "Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos". The purpose of this study is to evaluate the Picosure and Revlite Laser Systems for the treatment of unwanted tattoos.
What is the current status of trial NCT02110121?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2014-02. Estimated completion is 2017-03.
What conditions does trial NCT02110121 study?
This clinical trial studies the following conditions: Unwanted Tattoos.
What interventions are being tested in trial NCT02110121?
The interventions under investigation include: Picosure Laser System (DEVICE), Revlite Laser System (DEVICE).
Who is sponsoring clinical trial NCT02110121?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02110121 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unwanted Tattoos
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.